Regulation
Abbott secures FDA approval for Ultreon 3.0 imaging platform
Abbott received FDA approval and CE Mark for Ultreon 3.0, an AI-powered coronary imaging platform. The clearance enables the company to market the system in the US and European Union for intravascular imaging and analysis applications.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network